Unlocking the potential of Chinese herbal medicine residue-derived biochar as an efficient adsorbent for high-performance tetracycline removal.

This study employed hydrothermal carbonization (HTC) in conjunction with ZnCl2 activation and pyrolysis to produce biochar from one traditional Chinese medicine astragali radix (AR) residue. The resultant biochar was evaluated as a sustainable adsorbent for tetracycline (TC) elimination from water. The adsorption performance of TC on two micropore-rich AR biochars, AR@ZnCl2 (1370 m2 g-1) and HAR@ZnCl2 (1896 m2 g-1), was comprehensively evaluated using adsorption isotherms, kinetics, and thermodynamics. By virtue of pore diffusion, π-π interaction, electrostatic attraction, and hydrogen bonding, the prepared AR biochar showed exceptional adsorption properties for TC. Notably, the maximum adsorption capacity (930.3 mg g-1) of TC on HAR@ZnCl2 can be achieved when the adsorbent dosage is 0.5 g L-1 and C0 is 500 mg L-1 at 323 K. The TC adsorption on HAR@ZnCl2 took place spontaneously. Furthermore, the impact of competitive ions behavior is insignificant when coexisting ion concentrations fall within the 10-100 mg L-1 range. Additionally, the produced biochar illustrated good economic benefits, with a payback of 701 $ t-1. More importantly, even after ten cycles, HAR@ZnCl2 still presented great TC removal efficiency (above 77%), suggesting a good application prosperity. In summary, the effectiveness and sustainability of AR biochar, a biowaste-derived product, were demonstrated in its ability to remove antibiotics from water, showing great potential in wastewater treatment application.

Biochar Derived from Chinese Herb Medicine Residues for Rhodamine B Dye Adsorption.

In this study, one well-known CHM residue (Atropa belladonna L., ABL) was used to prepare biochar capable of adsorbing rhodamine B (RhB) with an ultrahigh surface area for the first time. Three micropore-rich ABL biochars including ABL@ZnCl2 (1866 m2/g), ABL@H3PO4 (1488 m2/g), and ABL@KOH (590 m2/g) were obtained using the one-step carbonization method with activation agents (ZnCl2, H3PO4, and KOH) via chemical activation and carbonization at 500 °C, and their adsorption performance for RhB was systematically studied with adsorption kinetics, isotherms, and thermodynamics. Through pore diffusion, π-π interaction, and hydrogen bonding, ABL biochar had excellent adsorption performance for RhB. Moreover, when C 0 was 200 mg/L, biochar dosage was 1 g/L, and the contact time was 120 min; the maximum RhB adsorption capacity and removal efficiency on ABL@ZnCl2 and ABL@H3PO4 were 190.63 mg/g, 95% and 184.70 mg/g, 92%, respectively, indicating that it was feasible to prepare biochar from the ABL residue for RhB adsorption. The theoretical maximum adsorption capacities of ABL@ZnCl2 and ABL@H3PO4 for RhB were 263.19 mg/g and 309.11 mg/g at 25 °C, respectively. Furthermore, the prepared biochar showed good economic applicability, with pay back of USD 972/t (ABL@ZnCl2) and USD 987/t (ABL@H3PO4), respectively. More importantly, even after five cycles, ABL@H3PO4 biochar still showed great RhB removal efficiency, suggesting that it had a good application prospect and provided a new method for the resource utilization of traditional CHM residues. Additionally, pore diffusion, π-π interactions, and hydrogen bonding all play roles in the physical adsorption of RhB on ABL biochar. π-π interactions dominated in the early stage of RhB adsorption on ABL@H3PO4, while pore diffusion played a crucial role in the whole adsorption process on both adsorbents.

Catalpol provides protective effects against cerebral ischaemia/reperfusion injury in gerbils.

OBJECTIVES: To investigate the protective effect of catalpol on cerebral ischaemia/reperfusion (CI/R) injury in gerbils and further explore the underlying mechanism. METHODS: A gerbil model of CI/R was prepared by bilateral common carotid occlusion for 10 min followed by 6 h reperfusion. Catalpol (5, 10 or 20 mg/kg per day) was injected intraperitoneally for 3 days before the carotid occlusion. Stroke index was measured during the reperfusion. The contents of endogenous neuropeptides, endothelin-1 (ET-1) and calcitonin gene-related peptide in plasma were evaluated by radioimmunoassay. Superoxide dismutase (SOD) and malondialdehyde (MDA) in brain tissue homogenate were also examined. KEY FINDINGS: The results showed that catalpol significantly improved the stroke index compared with CI/R control group (P < 0.05 or P < 0.01). Catalpol significantly increased the activity of SOD at the doses of 10 and 20 mg/kg (P ≤ 0.05), decreased the brain MDA content and the plasma level of ET-1 at the doses of 10 and 20 mg/kg (P ≤ 0.01). CONCLUSIONS: These data suggested that the efficacy of catalpol pretreatment on CI/R injury may be attributed to reduction of free radicals and inhibition of lipid peroxidation and ET-1 production.